s 55746
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02920697)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Apoptosis regulator Bcl-2INHIBITOR
BCL2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- s 055746
- s 55746
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02920541 | Phase 1 | Jan 1, 2015 | Servier, The Alfred Hospital |
| NCT02920697 | Phase 1 | Mar 1, 2014 | Servier, University of Nantes |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Servier | For profit | 2 | 2 | 1 | 2014 |
| The Alfred Hospital | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Nantes | Academic/Hospital | 1 | 0 | 1 | 2014 |
3 organizations
Page 1 / 1